Skip to content

Clinical trials

Withdrawn Lymphoma, B-Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Status: Withdrawn Country / region: China Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20171
20201
20212
20222
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zhujiang Hospital2
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China1
Dizal Pharmaceuticals1
Fuda Cancer Hospital, Guangzhou1
Kunming Hope of Health Hospital1
Shanghai Pudong Hospital1
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd1
The First Affiliated Hospital of Soochow University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell9
Burkitt Lymphoma2
Leukemia, B-Cell2
Lymphoma2
Leukemia, Myeloid, Acute1
Multiple Myeloma1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.